Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2014 16:01 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Reports Second Quarter 2014 Results

LA JOLLA, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines...
July 17, 2014 07:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Initiates Pivotal Phase 2/3 Clinical Trial for SD-809 in Tardive Dyskinesia

LA JOLLA, Calif., July 17, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
July 16, 2014 16:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Announces Completion of Follow on Offering and Exercise of Underwriters' Option to Purchase Additional Shares

LA JOLLA, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
July 11, 2014 08:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Announces Pricing of Follow On Offering

LA JOLLA, Calif., July 11, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
June 23, 2014 16:40 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Announces Data From Interim Analysis of ARC-HD Switch Trial Demonstrating Clinical Activity of SD-809

LA JOLLA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
May 28, 2014 08:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex to Present at Jefferies Global Healthcare Conference

LA JOLLA, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines...
May 13, 2014 16:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Reports 2014 First Quarter Results

LA JOLLA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines...